Molecular testing for ENG, ACVRL1, and SMAD4 mutations is not included in the currently used diagnostic criteria for HHT, but testing is usually performed when there is a strong clinical suspicion of HHT in patients not fulfilling the diagnostic criteria, and for testing family members of HHT patients. Here, ENG is linked to hereditary hemorrhagic telangiectasia.